AI Proteins
@AI_Proteins
Followers
3K
Following
148
Media
3
Statuses
78
better medicines, created rapidly through de novo protein design
Boston, USA
Joined September 2021
RT @bahl_lab: It was an honor to speak from the main stage at @TEDTalks last week about our work at @AI_Proteins
0
4
0
RT @bahl_lab: I am so grateful to be back on the TED stage this week in Vancouver to share an update on our story. In the 6 years since my….
0
11
0
Welcome Phil Brandish, Chief Development Officer, to the AI Proteins team!.
0
0
9
RT @Business_AI: Biotechnology firm @AI_Proteins has partnered with the @Mizzou to advance the use of de novo designed miniproteins for tar….
0
2
0
I’m excited to share that I am now the CEO of @AI_Proteins! I’m grateful to continue leading this exceptional team as we build upon the strong foundation that we’ve established since launching the company in 2021. 🧵👇.
0
0
7
RT @bahl_lab: So, I might have ended up on the jumbotron at the Celtics game proudly wearing my @AI_Proteins colors
0
2
0
See Mireia Solà Colom @MireiaSol6, Head of Immunotherapeutics at @AI_Proteins, as she presents our latest progress on the design and optimization of immune cell engagers built from our de novo #miniproteins.
for the folks who weren't able to join for @MireiaSol6's brilliant presentation last week to cap off our 2024 seminar series, you can check out the recording 👇.
0
2
2
RT @mellases: Exciting times at @AI_Proteins! We are getting so close to see our drugs helping patients!.
0
4
0
You can read more about our exciting new collaboration with Bristol Myers Squibb in this coverage from Fierce Biotech.
1
2
5
@AI_Proteins is excited to partner with @bmsnews to develop novel miniprotein-based therapeutics. This collaboration will leverage our cutting-edge AI-driven platform to design and optimize miniproteins with the potential to transform patient outcomes.
1
9
26
We're excited that Mireia Solà Colom @MireiaSol6, our Head of Immunotherapeutics will share some of our latest work on immune cell engagers at @ProteinBoston next month!.
There's just one meeting left in 2024, and we have a spectacular seminar by @MireiaSol6 lined up for you!. Join us at 7pm in Room 181, Building 68, MIT on Wednesday, December 11th. "De novo design of miniprotein-based natural killer cell engagers".
1
1
2
Our founder, President and CSO Chris Bahl @bahl_lab went to the @Falling_Walls Science Summit last week to explain how we make #miniprotein therapeutics with unprecedented ability to control cellular behavior - you can check out the recording 👇.
1
3
3
RT @binder_finder_: Excited to share that a de novo designed miniprotein that myself, @bahl_lab, and @frankteets created during my post-doc….
0
16
0
RT @bahl_lab: so excited that our field of protein design has been awarded a @NobelPrize, and it's amazing to see my postdoc advisor receiv….
0
9
0
We are honored to be selected as a @Falling_Walls Venture winner! Our de novo designed #miniprotein therapeutics promise to be a game changer for patients, and this recognition is a testament to the hard work and dedication of our team.
These science start-ups that will pitch for the title Falling Walls #ScienceBreakthrough of the Year 2024 at the #FallingWalls #ScienceSummit24:. 🏆 ActiTrexx 🏆 AI Proteins @AI_Proteins 🏆 ARQUE Systems 🏆 Bioeutectics 🏆 Cyclize 🏆 DeepEn 🏆 ecoLocked 🏆 ElectraLith 🏆 Exazyme
2
2
21
RT @bahl_lab: I'm extremely grateful to the stellar team of collaborators that made it a joy to work on this story: @MireiaSol6 Jelena Vuči….
0
4
0
RT @ipiproteins: Excited to share work from @bahl_lab! When at IPI, the team used #AI to interrogate the functional sequence landscape of #….
0
1
0